CK Life Sciences Int'l., (Holdings) Inc.

DB:LSI Stock Report

Market Cap: €1.0b

CK Life Sciences Int'l. (Holdings) Management

Management criteria checks 3/4

CK Life Sciences Int'l. (Holdings)'s CEO is Lance Richard Yuen, appointed in Sep 2024, has a tenure of less than a year. total yearly compensation is HK$6.88M, comprised of 47.1% salary and 52.9% bonuses, including company stock and options. directly owns 0.024% of the company’s shares, worth €244.11K. The average tenure of the management team and the board of directors is 14.7 years and 6.5 years respectively.

Key information

Lance Richard Yuen

Chief executive officer

HK$6.9m

Total compensation

CEO salary percentage47.1%
CEO tenureless than a year
CEO ownership0.02%
Management average tenure14.7yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Lance Richard Yuen's remuneration changed compared to CK Life Sciences Int'l. (Holdings)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024HK$7mHK$3m

-HK$127m

Compensation vs Market: Lance Richard's total compensation ($USD887.48K) is below average for companies of similar size in the German market ($USD1.28M).

Compensation vs Earnings: Insufficient data to compare Lance Richard's compensation with company performance.

CEO

Lance Richard Yuen (58 yo)

less than a year

Tenure

HK$6,878,000

Compensation

Mr. Lee Yuen, also known as Lance Richard, is Executive Director, Vice President & Chief Executive Officer of CK Life Sciences Int'l. (Holdings) Inc. from September 20, 2024. Mr. Yuen joined the Group in S...

Leadership Team

NamePositionTenureCompensationOwnership
Tzar Kuoi Li
Executive Chairman 23.1yrsHK$125.00k0.023%
€ 238.8k
Lee Yuen
VP, CEO & Executive Directorless than a yearHK$6.88m0.024%
€ 244.1k
Hing Lam Kam
President & Executive Director22.9yrsHK$3.08m0.041%
€ 416.6k
Tak Chuen IP
Senior VPno dataHK$1.10m0.023%
€ 238.8k
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director6.5yrsHK$6.44mno data
Wun Lam Wong
Chief Financial Officerno datano datano data
Pak To Wu
Chief Operating Officer of Global Operationsno datano datano data
Yau Wong
General Manager of Human Resources & Administrationno datano datano data
Ching Sze Chiu
General Counselno datano datano data
Sze Ho
Vice President of Corporate Developmentno datano datano data
Wai Che Tong Barnes
Chief Corporate Affairs Officerno datano datano data
Eirene Yeung
Company Secretary23.3yrsno datano data

14.7yrs

Average Tenure

59.5yo

Average Age

Experienced Management: LSI's management team is seasoned and experienced (14.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tzar Kuoi Li
Executive Chairman 23.1yrsHK$125.00k0.023%
€ 238.8k
Lee Yuen
VP, CEO & Executive Directorless than a yearHK$6.88m0.024%
€ 244.1k
Hing Lam Kam
President & Executive Directorno dataHK$3.08m0.041%
€ 416.6k
Tak Chuen IP
Senior VPno dataHK$1.10m0.023%
€ 238.8k
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director6.5yrsHK$6.44mno data
Eva Kwok
Independent Non-Executive Director22.9yrsHK$100.00k0.0021%
€ 21.2k
Keith Frankel
Co-Chairman of Vitaquest International LLCno datano datano data
Peter Peace Tulloch
Non-Executive Director23.1yrsHK$75.00k0.011%
€ 111.4k
Ying Choi Yu
Deputy Chairmanless than a yearHK$15.26m0.023%
€ 238.8k
Kai Cheong Kwan
Independent Non-executive Director10.2yrsHK$155.00kno data
Donald Jeffrey Roberts
Independent Non-Executive Director4.8yrsHK$205.00kno data
Joseph Paul Tighe
Independent Non-Executive Director5.9yrsHK$205.00kno data

6.5yrs

Average Tenure

70yo

Average Age

Experienced Board: LSI's board of directors are considered experienced (6.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 21:10
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CK Life Sciences Int'l., (Holdings) Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jayaprabha DhavaleVirtua Research Inc.